Ecolab stock enters 2027 with stronger margin momentum
π Ecolab reported a broad acceleration in third-quarter operating performance across its core businesses and growth engines.
π° Reported sales rose 13% in the quarter ended September 30, while organic sales growth accelerated to 7%.
π The Global High-Tech segment delivered 63% organic sales growth, significantly outpacing other divisions.
𧬠Life Sciences organic sales grew by 17%, contributing to overall portfolio expansion.
π» Ecolab Digital sales surged 34% to $129 million, establishing a new technology-led growth channel.
π Organic operating income increased 11%, with the margin expanding to 19.6%.
πΉ Pricing accelerated by 5%, successfully offsetting higher commodity costs and supporting stronger results.
π€ Adjusted diluted earnings per share rose 5% to $2.18, despite a 5% decline in reported diluted EPS due to acquisition-related amortization.
π― Management forecasts 2027 organic sales growth at the upper end of its 5% to 7% target range.
π΅ Ecolab projects an adjusted operating income margin of 20% for 2027, reflecting continued margin expansion.
β οΈ Acquisition-related amortization and financing costs remain a near-term headwind to earnings growth.
π The outlook is sensitive to CoolIT-related amortization and financing costs impacting the bottom line.
π° Analysts project adjusted diluted earnings per share between $8.10 and $8.20 for 2026.
π Fourth-quarter adjusted diluted earnings per share are projected at $2.13 to $2.23.
π’ Ecolab stock traded at 274.30 euros on November 10, 2026, reflecting positive market sentiment.
- Ecolab reported broad third-quarter operating acceleration with sales rising 13% in the quarter ended September 30.
- Organic sales growth accelerated to 7%, demonstrating strong underlying demand across core businesses.
- Global High-Tech delivered exceptional 63% organic sales growth, while Life Sciences grew organically by 17%.
- Ecolab Digital sales increased 34% to $129 million, adding a significant technology-led growth channel to the portfolio.
- Organic operating income rose 11%, and the organic operating income margin expanded to 19.6%.
- Pricing accelerated to 5%, which helped offset higher commodity costs and supported the stronger result.
- Management expects 2027 organic sales growth at the upper end of its target range with an adjusted operating income margin of 20%.
- Adjusted diluted earnings per share increased 5% to $2.18, indicating improved profitability on a non-GAAP basis.